Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: A double-blinded placebo-controlled pilot study

Parkinson disease (PD) is associated with cognitive impairment. We aimed to determine the effects of intranasal insulin (INI) on cognition and motor performance in PD. This was a proof of concept, randomized, double-blinded, placebo-controlled trial evaluating the effects of 40 international units (...

Descripción completa

Detalles Bibliográficos
Autores principales: Novak, Peter, Pimentel Maldonado, Daniela Arantxa, Novak, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483338/
https://www.ncbi.nlm.nih.gov/pubmed/31022213
http://dx.doi.org/10.1371/journal.pone.0214364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483338/
https://www.ncbi.nlm.nih.gov/pubmed/31022213
http://dx.doi.org/10.1371/journal.pone.0214364

Ejemplares similares